XBRUAZE
Market cap4.80bUSD
Dec 20, Last price
18.86EUR
1D
-0.47%
1Q
2.44%
IPO
-31.17%
Name
Azelis Group NV
Chart & Performance
P/E
25.87
P/S
1.11
EPS
0.73
Div Yield, %
1.47%
Shrs. gr., 5y
0.53%
Rev. gr., 5y
74.47%
Revenues
4.15b
+0.66%
Net income
178m
-16.65%
CFO
426m
+15.51%
Dividend
Jun 28, 20240.22 EUR/sh
Earnings
Mar 05, 2025
Profile
Azelis Group NV engages in the distribution of specialty chemicals and food ingredients in Belgium and internationally. It serves various segments in life sciences, including personal care, pharma, food and health, specialty agri/horti, and homecare and industrial chemicals; and industrial chemicals industry, such as CASE, rubber and plastic additives, lubricants and metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper applications. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium. Azelis Group NV operates as a subsidiary of Akita I S.À R.L.
IPO date
Sep 17, 2021
Employees
3,800
Domiciled in
BE
Incorporated in
BE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 4,152,225 0.66% | 4,124,898 45.90% | 2,827,296 20.88% | |||
Cost of revenue | 3,764,649 | 3,324,906 | 2,335,266 | |||
Unusual Expense (Income) | ||||||
NOPBT | 387,576 | 799,992 | 492,030 | |||
NOPBT Margin | 9.33% | 19.39% | 17.40% | |||
Operating Taxes | 57,926 | 95,791 | 49,973 | |||
Tax Rate | 14.95% | 11.97% | 10.16% | |||
NOPAT | 329,650 | 704,201 | 442,057 | |||
Net income | 177,704 -16.65% | 213,193 214.65% | 67,756 -4.52% | |||
Dividends | (67,772) | (7,012) | ||||
Dividend yield | 1.27% | 0.11% | ||||
Proceeds from repurchase of equity | 196,592 | 571,459 | 930,000 | |||
BB yield | -3.69% | -9.21% | -15.76% | |||
| Debt | ||||||
Debt current | 125,117 | 176,125 | 118,328 | |||
Long-term debt | 1,777,599 | 1,361,120 | 963,386 | |||
Deferred revenue | 12,949 | |||||
Other long-term liabilities | 86,611 | 111,386 | 9,655 | |||
Net debt | 1,409,748 | 1,257,092 | 938,886 | |||
| Cash flow | ||||||
Cash from operating activities | 425,761 | 368,594 | 89,896 | |||
CAPEX | (15,485) | (18,443) | (18,288) | |||
Cash from investing activities | (600,055) | (572,108) | (652,171) | |||
Cash from financing activities | 304,922 | 341,039 | 523,825 | |||
FCF | 359,333 | 634,125 | 282,640 | |||
| Balance | ||||||
Cash | 484,934 | 268,440 | 142,815 | |||
Long term investments | 8,034 | 11,713 | 13 | |||
Excess cash | 285,357 | 73,908 | 1,463 | |||
Stockholders' equity | 10,530,732 | 6,140,908 | 5,868,365 | |||
Invested Capital | 4,253,930 | 3,877,048 | 3,261,258 | |||
ROIC | 8.11% | 19.73% | 15.45% | |||
ROCE | 8.15% | 19.32% | 14.48% | |||
| EV | ||||||
Common stock shares outstanding | 240,102 | 233,846 | 233,846 | |||
Price | 22.18 -16.37% | 26.52 5.11% | 25.23 | |||
Market cap | 5,325,462 -14.13% | 6,201,600 5.11% | 5,899,938 | |||
EV | 10,748,866 | 10,809,305 | 10,315,063 | |||
EBITDA | 488,675 | 884,725 | 551,414 | |||
EV/EBITDA | 22.00 | 12.22 | 18.71 | |||
Interest | 121,950 | 38,218 | 49,899 | |||
Interest/NOPBT | 31.46% | 4.78% | 10.14% | |||